Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-10 Sale |
2022-11-14 4:51 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
53,926 | $17.05 | $919,589 | 434,455 (Indirect Direct) |
View |
| 2022-10-24 Sale |
2022-10-26 7:09 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
41,174 | $17.01 | $700,355 | 488,381 (Indirect Direct) |
View |
| 2022-10-17 Sale |
2022-10-19 4:49 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
52,037 | $16.57 | $862,109 | 529,555 (Indirect Direct) |
View |
| 2022-10-07 Sale |
2022-10-11 4:35 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
7,324 | $16.16 | $118,349 | 581,592 (Indirect Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 5:58 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
45,539 | $16.45 | $749,002 | 588,916 (Indirect Direct) |
View |
| 2022-06-17 Sale |
2022-06-21 4:57 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
19,565 | $15.14 | $296,269 | 634,455 (Indirect Direct) |
View |
| 2021-06-29 Purchase |
2021-07-01 6:29 pm |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
187,500 | $16 | $3,000,000 | 2,834,910 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-12 Option Award |
2024-06-13 4:30 pm |
N/A 2034-06-12 |
Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director |
22,100 | $0 | 22,100 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
20,543 | $0 | 20,543 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
4,660 | $0 | 443,622 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:09 pm |
N/A 2033-06-15 |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
31,238 | $0 | 31,238 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:28 pm |
N/A 2033-06-13 |
Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:53 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
20,410 | $0 | 459,372 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 4:53 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
4,507 | $0 | 459,372 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 6:43 pm |
N/A 2032-06-16 |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
15,619 | $0 | 15,619 (Indirect) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:31 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:36 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
20,257 | $0 | 674,277 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
3,356 | $0 | 674,277 (Direct) |
View |
| 2021-06-29 Conversion |
2021-07-01 6:29 pm |
N/A N/A |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
12,288,426 | $0 | 2,834,910 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:18 pm |
N/A 2031-06-23 |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
31,238 | $0 | 31,238 (Indirect) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:01 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director |
47,132 | $0 | 47,132 (Direct) |
View |
Ownership |
2021-06-24 6:32 pm |
N/A N/A |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP ELMS STEVE Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N 10% Owner |
0 | $0 | 2,647,410 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:12 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:27 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
16,500 | $0 | 667,164 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:27 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
7,333 | $0 | 667,164 (Direct) |
View |